UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China
Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore. The post UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China appeared first on MedCity News.